Organigram

Forecast & Rating5 analysts currently cover Organigram, with about 80.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $3.26, about 152.7% upside from the current price of $1.29. Historically, about 16.7% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Organigram closely still see room for the stock to rise. Data as of Aug 12, 2026; for reference only and not investment advice.